News

Aptus Clinical enters into a global partnership agreement with Artelo Biosciences

Press Release Artelo Biosciences ENTERS INTO GLOBAL R&D PARTNERSHIP WITH SYNGENE INTERNATIONAL and APTUS CLINICAL for the clinical development of ART27.13 in oncology LA JOLLA, CA – June 5, 2018 – Artelo Biosciences, Inc. (OTCQB: ARTL), a biopharmaceutical company focused…

Read more >
June 12 2018 0 comments

CEO gives a talk at the Advanced Therapies & Regenerative Medicine Congress

Aptus Clinical CEO Steve McConchie discusses Aptus Clinical and their role in iMATCH at the World Advanced Therapies & Regenerative Medicine Congress May 2018. https://twitter.com/aptusclinical/status/999983518720712704

Read more >
June 6 2018 0 comments

Aptus Clinical Awarded Part of £7m Government Investment

Manchester-based Aptus Clinical are one of twelve partners receiving government funding to ensure that more patients benefit from a new generation of medicines. Nearly £7m has been awarded to the Innovate Manchester Advanced Therapy Centre Hub (iMATCH) by Innovate UK…

Read more >
April 6 2018 0 comments

Delighted to be part of iMATCH

A recently formed Manchester health consortium, led by The Christie, has been awarded nearly £7 million of funding to ensure more patients benefit from a new generation of disease-fighting drugs for cancer and non-cancer illnesses. Manchester is one of only…

Read more >
January 18 2018 0 comments